When you are dedicated to studying fungal diseases, you learn something new every day. Angiogenesis, for example, is the process whereby “break-away” cancer cells leave an original cancer site and begin to grow elsewhere in the body. New blood supply growth around these “break-away” cells enable our food supply to feed the new cancer cells and cancer metastasis begins.
But I didn’t know that nerve cells were also involved in the spread of cancer. As reported in a new article (1), activation of nerve cells not only plays a role in the formation of breast cancer, but their presence also has to do with breast cancer metastasis as well. Researchers have discovered that an old FDA approved drug can halt this metastasis, at least in mouse models. The anti-parasite medication, aprepitant will begin test trials on humans before too long and in my opinion, it will work. Why? Because it is not only an anti-parasite medication, but it is also an antifungal medication. Said the journal Virulence in 2020, “This study presents aprepitant as a novel, potent, and broad-spectrum azole chemosensitizing agent that warrants further investigation. “ Azole drugs are antifungal drugs.
As you know, I believe that far too often we are calling it “cancer” when it may be “fungus.” Many of the available antifungal medications, not coincidentally, also have anti-cancer properties. One day, they may stumble onto this very important realization. Until such time, at very least you now know this!
Sources
Related Articles
The Many Similarities Between Cancer and Fungus
One Man’s Hypothesis On An Unknown Cause of Cancer
Still have questions?
Join our LIVE Q&A stream every week if you would like to ask a question! Learn more about the live show and join in here: KTC Too! – Doug Kaufmann’s Know the Cause